Search: id:"swepub:oai:DiVA.org:liu-76028" >
Design of xanthone ...
Design of xanthone propionate photolabile protecting group releasing acyclovir for the treatment of ocular herpes simplex virus
-
- Blake, Jessie A (author)
- University of Ottawa
-
- Bareiss, Bettina (author)
- University of Ottawa
-
- Jimenez, Liliana (author)
- University of Ottawa
-
show more...
-
- Griffith, May (author)
- Linköpings universitet,Oftalmiatrik,Hälsouniversitetet
-
- Scaiano, J C (author)
- Linköpings universitet,Oftalmiatrik,Hälsouniversitetet
-
show less...
-
(creator_code:org_t)
- 2012-03-01
- 2012
- English.
-
In: Photochemical and Photobiological Sciences. - : Royal Society of Chemistry. - 1474-905X .- 1474-9092. ; 11:3, s. 539-547
- Related links:
-
https://urn.kb.se/re...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- We have attached the antiviral drug acyclovir (ACV) to a xanthone photolabile protecting group (or photocage) through the O6 position of acyclovir, a procedure designed for the treatment of ocular herpes simplex virus infections. Acyclovir is photoreleased from the photocage, under physiological conditions, with a quantum yield (Phi(ACV release)) of 0.1-0.3 and an uncaging cross section (Phi.epsilon) of 450-1350 M cm(-1). We demonstrate that this photorelease method outcompetes alternative reaction pathways, such as protonation. Furthermore, complete release of the drug is theoretically possible given a sufficient dose of light. Surprisingly the acyclovir photocage, also showed some antiviral activity towards HSV-1.
Keyword
- MEDICINE
- MEDICIN
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database